Trial Profile
The Study of Stepwise Introduction of Insulin Analog Mixture as a Post-marketing Clinical Trial of Lispro Mix 50/50 to Evaluate Efficacy and Safety in Type 2 Diabetic Patients With Inadequate Glycemic Control on Oral Therapy. (SIMPLE Study).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin neutral protamine lispro/insulin lispro (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SIMPLE
- Sponsors Eli Lilly and Company
- 10 Apr 2012 Actual patient number chnaged from (125) to (135) ss reported by ClinicalTrials.gov.
- 27 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 May 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.